Targeting Inflammation to Treat Cardiovascular Aging

PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Vascular StiffnessEndothelial DysfunctionDiastolic Dysfunction
Interventions
DRUG

Salsalate

4 weeks of daily salsalate

DRUG

Placebo (for salsalate)

4 week of daily placebo

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
lead

Gary L. Pierce

OTHER

NCT01775865 - Targeting Inflammation to Treat Cardiovascular Aging | Biotech Hunter | Biotech Hunter